On the other hand, investigators have found that patients diagnosed with type 2 diabetes and metabolic syndrome exhibited no improvements in fasting glucose, fasting insulin, or energy intake, despite increased GLP-1 (11.4 ± 1.9 vs. 17.0 ± 3.2, p = 0.049), with 40 g/day of high-amylose maize consumption [43]. The gene discussed is INS; the disease is type 2 diabetes mellitus.